Difference between revisions of "LncRNAWiki:C"

From LncRNAWiki
Jump to: navigation, search
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''C1QTNF9B-AS1'' |C1QTNF9B-AS1 |PCOTH |C1QTNF9B antisense ...")
 
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 +
 +
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 +
Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] '''C''' [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']]
 +
</div>
 +
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
Line 5: Line 10:
 
!Alias
 
!Alias
 
!Description
 
!Description
 +
!Disease
 
|-
 
|-
 
|''C1QTNF9B-AS1''
 
|''C1QTNF9B-AS1''
Line 10: Line 16:
 
|PCOTH
 
|PCOTH
 
|C1QTNF9B antisense RNA 1
 
|C1QTNF9B antisense RNA 1
 +
|prostate cancer
 
|-
 
|-
 
|''C21orf91-OT1''
 
|''C21orf91-OT1''
Line 15: Line 22:
 
|D21S2089E
 
|D21S2089E
 
|C21orf91 overlapping transcript 1
 
|C21orf91 overlapping transcript 1
 +
|_
 
|-
 
|-
 
|''C5orf66-AS1''
 
|''C5orf66-AS1''
 
|[[C5orf66-AS1]]
 
|[[C5orf66-AS1]]
−
|CTC-276P9.1, Epist
+
|"CTC-276P9.1, Epist"
 
|C5orf66 antisense RNA 1
 
|C5orf66 antisense RNA 1
 +
|esophageal squamous cell carcinoma
 
|-
 
|-
 
|''C5orf66-AS2''
 
|''C5orf66-AS2''
Line 25: Line 34:
 
|N/A
 
|N/A
 
|C5orf66 antisense RNA 2
 
|C5orf66 antisense RNA 2
 +
|_
 
|-
 
|-
 
|''C8orf34-AS1''
 
|''C8orf34-AS1''
Line 30: Line 40:
 
|N/A
 
|N/A
 
|C8orf34 antisense RNA 1
 
|C8orf34 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CACNA1G-AS1''
 
|''CACNA1G-AS1''
Line 35: Line 46:
 
|N/A
 
|N/A
 
|CACNA1G antisense RNA 1
 
|CACNA1G antisense RNA 1
 +
|keloid
 
|-
 
|-
 
|''CAHM''
 
|''CAHM''
Line 40: Line 52:
 
|LINC00468
 
|LINC00468
 
|colon adenocarcinoma hypermethylated (non-protein coding)
 
|colon adenocarcinoma hypermethylated (non-protein coding)
 +
|colorectal neoplasia.
 
|-
 
|-
 
|''CAPN10-AS1''
 
|''CAPN10-AS1''
Line 45: Line 58:
 
|locus959
 
|locus959
 
|CAPN10 antisense RNA 1 (head to head)
 
|CAPN10 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CAR Intergenic 10''
 
|''CAR Intergenic 10''
 
|[[NONHSAT016928]],[[lnc-FANK1-3:1]]
 
|[[NONHSAT016928]],[[lnc-FANK1-3:1]]
−
|Intergenic10, CR611911, AK055628
+
|"Intergenic10, CR611911, AK055628"
 
|Chromatin Associated RNA 10
 
|Chromatin Associated RNA 10
 +
|_
 
|-
 
|-
 
|''CARD8-AS1''
 
|''CARD8-AS1''
Line 55: Line 70:
 
|LOC100505812
 
|LOC100505812
 
|CARD8 antisense RNA 1
 
|CARD8 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CARMN''
 
|''CARMN''
Line 60: Line 76:
 
|CARMEN
 
|CARMEN
 
|cardiac mesoderm enhancer-associated non-coding RNA
 
|cardiac mesoderm enhancer-associated non-coding RNA
 +
|_
 
|-
 
|-
 
|''CASC11''
 
|''CASC11''
 
|[[CASC11]]
 
|[[CASC11]]
−
|TCONSN/A00014535, LINC00990, CARLo-7
+
|"TCONSN/A00014535, LINC00990, CARLo-7"
 
|cancer susceptibility candidate 11 (non-protein coding)
 
|cancer susceptibility candidate 11 (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CASC15''
 
|''CASC15''
Line 70: Line 88:
 
|N/A
 
|N/A
 
|cancer susceptibility candidate 15 (non-protein coding)
 
|cancer susceptibility candidate 15 (non-protein coding)
 +
|metastatic melanoma
 
|-
 
|-
 
|''CASC19''
 
|''CASC19''
Line 75: Line 94:
 
|CARLo-6
 
|CARLo-6
 
|cancer susceptibility candidate 19 (non-protein coding)
 
|cancer susceptibility candidate 19 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''CASC2''
 
|''CASC2''
Line 80: Line 100:
 
|N/A
 
|N/A
 
|cancer susceptibility candidate 2 (non-protein coding)
 
|cancer susceptibility candidate 2 (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CASC21''
 
|''CASC21''
Line 85: Line 106:
 
|CARLo-2
 
|CARLo-2
 
|cancer susceptibility candidate 21 (non-protein coding)
 
|cancer susceptibility candidate 21 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CASC22''
 
|''CASC22''
 
|[[CASC22]]
 
|[[CASC22]]
−
|TCONSN/A00024290, LincRNA-ENST00000515084
+
|"TCONSN/A00024290, LincRNA-ENST00000515084"
 
|cancer susceptibility candidate 22 (non-protein coding)
 
|cancer susceptibility candidate 22 (non-protein coding)
 +
|breast cancer
 
|-
 
|-
 
|''CASC8''
 
|''CASC8''
 
|[[CASC8]]
 
|[[CASC8]]
−
|LINC00860,CARLo-1
+
|"LINC00860,CARLo-1"
 
|cancer susceptibility candidate 8 (non-protein coding)
 
|cancer susceptibility candidate 8 (non-protein coding)
 +
|Colorectal Cancer,Lung Cancer
 
|-
 
|-
 
|''CASC9''
 
|''CASC9''
 
|[[CASC9]]
 
|[[CASC9]]
−
|LINC00981, ESCCAL-1
+
|"LINC00981, ESCCAL-1"
 
|cancer susceptibility candidate 9 (non-protein coding)
 
|cancer susceptibility candidate 9 (non-protein coding)
 +
|predicted esophageal squamous cell carcinoma
 
|-
 
|-
 
|''CBR3-AS1''
 
|''CBR3-AS1''
Line 105: Line 130:
 
|PlncRNA-1
 
|PlncRNA-1
 
|CBR3 antisense RNA 1
 
|CBR3 antisense RNA 1
 +
|esophageal squamous carcinoma cell
 
|-
 
|-
 
|''CCAT1''
 
|''CCAT1''
 
|[[NONHSAT129017]]
 
|[[NONHSAT129017]]
−
|CARLo-5, onco-lncRNA-40
+
|"CARLo-5, onco-lncRNA-40"
 
|colon cancer associated transcript 1 (non-protein coding)
 
|colon cancer associated transcript 1 (non-protein coding)
 +
|colorectal cancer,gastric cancer
 
|-
 
|-
 
|''CCAT2''
 
|''CCAT2''
 
|[[CCAT2]]
 
|[[CCAT2]]
−
|NCCP1, LINC00873
+
|"NCCP1, LINC00873"
 
|colon cancer associated transcript 2 (non-protein coding)
 
|colon cancer associated transcript 2 (non-protein coding)
 +
|non-small cell lung cancer
 
|-
 
|-
 
|''CCDC18-AS1''
 
|''CCDC18-AS1''
Line 120: Line 148:
 
|ENST00000440778.1
 
|ENST00000440778.1
 
|CCDC18 antisense RNA 1
 
|CCDC18 antisense RNA 1
 +
|Adolescent Idiopathic Scoliosis
 
|-
 
|-
 
|''CCDC26''
 
|''CCDC26''
 
|[[CCDC26]]
 
|[[CCDC26]]
−
|MGC27434, RAM
+
|"MGC27434, RAM"
 
|CCDC26 long non-coding RNA
 
|CCDC26 long non-coding RNA
 +
|glioma
 
|-
 
|-
 
|''CCEPR''
 
|''CCEPR''
Line 130: Line 160:
 
|CCHE1
 
|CCHE1
 
|cervical carcinoma expressed PCNA regulatory lncRNA
 
|cervical carcinoma expressed PCNA regulatory lncRNA
 +
|cervical cancer
 
|-
 
|-
 
|''CDKN1A-AS1''
 
|''CDKN1A-AS1''
Line 135: Line 166:
 
|p21NAT
 
|p21NAT
 
|CDKN1A antisense RNA 1
 
|CDKN1A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CDKN2B-AS1''
 
|''CDKN2B-AS1''
 
|[[NONHSAT130421]],[[lnc-C9orf53-2:1]]
 
|[[NONHSAT130421]],[[lnc-C9orf53-2:1]]
−
|ANRIL, p15AS, ENSG00000240498
+
|"ANRIL, p15AS, ENSG00000240498"
 
|CDKN2B antisense RNA 1
 
|CDKN2B antisense RNA 1
 +
|abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
 
|-
 
|-
 
|''CDR1-AS''
 
|''CDR1-AS''
 
|[[CDR1-AS]]
 
|[[CDR1-AS]]
−
|CDR1NAT, ciRS-7, CDR1as
+
|"CDR1NAT, ciRS-7, CDR1as"
 
|CDR1 antisense RNA
 
|CDR1 antisense RNA
 +
|_
 
|-
 
|-
 
|''CDRT7''
 
|''CDRT7''
 
|[[CDRT7]]
 
|[[CDRT7]]
−
|NCRNA00025, LINC00025
+
|"NCRNA00025, LINC00025"
 
|CMT1A duplicated region transcript 7 (non-protein coding)
 
|CMT1A duplicated region transcript 7 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CDRT8''
 
|''CDRT8''
Line 155: Line 190:
 
|N/A
 
|N/A
 
|CMT1A duplicated region transcript 8
 
|CMT1A duplicated region transcript 8
 +
|_
 
|-
 
|-
 
|''CECR3''
 
|''CECR3''
 
|[[CECR3]]
 
|[[CECR3]]
 
|N/A
 
|N/A
−
|cat eye syndrome chromosome region, candidate 3 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 3 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR5-AS1''
 
|''CECR5-AS1''
Line 165: Line 202:
 
|NCRNA00017
 
|NCRNA00017
 
|CECR5 antisense RNA 1
 
|CECR5 antisense RNA 1
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR7''
 
|''CECR7''
 
|[[CECR7]]
 
|[[CECR7]]
 
|SAHL1
 
|SAHL1
−
|cat eye syndrome chromosome region, candidate 7 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 7 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR9''
 
|''CECR9''
 
|[[CECR9]]
 
|[[CECR9]]
 
|N/A
 
|N/A
−
|cat eye syndrome chromosome region, candidate 9 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 9 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CEP83-AS1''
 
|''CEP83-AS1''
Line 180: Line 220:
 
|N/A
 
|N/A
 
|CEP83 antisense RNA 1 (head to head)
 
|CEP83 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CIRBP-AS1''
 
|''CIRBP-AS1''
Line 185: Line 226:
 
|MGC39338
 
|MGC39338
 
|CIRBP antisense RNA 1
 
|CIRBP antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CISTR''
 
|''CISTR''
 
|[[NONHSAT028496]]
 
|[[NONHSAT028496]]
−
|CISTR-ACT, CISTRACT, re52431
+
|"CISTR-ACT, CISTRACT, re52431"
 
|chondrogenesis-associated transcript
 
|chondrogenesis-associated transcript
 +
|_
 
|-
 
|-
 
|''CLRN1-AS1''
 
|''CLRN1-AS1''
Line 195: Line 238:
 
|UCRP
 
|UCRP
 
|CLRN1 antisense RNA 1
 
|CLRN1 antisense RNA 1
 +
|Usher syndrome type 3
 
|-
 
|-
 
|''COPG2IT1''
 
|''COPG2IT1''
 
|[[COPG2IT1]]
 
|[[COPG2IT1]]
−
|CIT1, NCRNA00170, COPG2AS
+
|"CIT1, NCRNA00170, COPG2AS"
 
|COPG2 imprinted transcript 1 (non-protein coding)
 
|COPG2 imprinted transcript 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CPS1-IT1''
 
|''CPS1-IT1''
 
|[[CPS1-IT1]]
 
|[[CPS1-IT1]]
−
|PRO0132, CPS1-IT
+
|"PRO0132, CPS1-IT"
 
|CPS1 intronic transcript 1
 
|CPS1 intronic transcript 1
 +
|_
 
|-
 
|-
 
|''CRNDE''
 
|''CRNDE''
 
|[[Lnc-IRX3-4:2]]
 
|[[Lnc-IRX3-4:2]]
−
|LOC643911, LINC00180, CRNDEP
+
|"LOC643911, LINC00180, CRNDEP"
 
|colorectal neoplasia differentially expressed (non-protein coding)
 
|colorectal neoplasia differentially expressed (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CSNK1G2-AS1''
 
|''CSNK1G2-AS1''
Line 215: Line 262:
 
|MGC39696
 
|MGC39696
 
|CSNK1G2 antisense RNA 1
 
|CSNK1G2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CSTF3-AS1''
 
|''CSTF3-AS1''
Line 220: Line 268:
 
|N/A
 
|N/A
 
|CSTF3 antisense RNA 1 (head to head)
 
|CSTF3 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CTBP1-AS''
 
|''CTBP1-AS''
Line 225: Line 274:
 
|PCAT10
 
|PCAT10
 
|CTBP1 antisense RNA
 
|CTBP1 antisense RNA
 +
|prostate cancer
 
|-
 
|-
 
|''CTBP1-AS2''
 
|''CTBP1-AS2''
Line 230: Line 280:
 
|MGC21675
 
|MGC21675
 
|CTBP1 antisense RNA 2 (head to head)
 
|CTBP1 antisense RNA 2 (head to head)
 +
|_
 
|-
 
|-
 
|''CYP1B1-AS1''
 
|''CYP1B1-AS1''
Line 235: Line 286:
 
|MGC34824
 
|MGC34824
 
|CYP1B1 antisense RNA 1
 
|CYP1B1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CYP4A22-AS1''
 
|''CYP4A22-AS1''
 
|[[ENST00000444042.2]]
 
|[[ENST00000444042.2]]
−
|Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506
+
|"Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506"
 
|CYP4A22 antisense RNA 1
 
|CYP4A22 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CYP51A1-AS1''
 
|''CYP51A1-AS1''
 
|[[CYP51A1-AS1]]
 
|[[CYP51A1-AS1]]
−
|ENST00000453068, LRRD1-AS1
+
|"ENST00000453068, LRRD1-AS1"
 
|CYP51A1 antisense RNA 1
 
|CYP51A1 antisense RNA 1
 +
|renal cell carcinoma
 
|-
 
|-
 
|''CYYR1-AS1''
 
|''CYYR1-AS1''
Line 250: Line 304:
 
|cysteine and tyrosine rich 1 antisense RNA 1
 
|cysteine and tyrosine rich 1 antisense RNA 1
 
|N/A
 
|N/A
 +
|_
 +
|-
 +
|''CCND2-AS1''
 +
|[[CCND2-AS1]]
 +
|N/A
 +
|CCND2 antisense RNA 1
 +
|glioma
 +
|-
 +
|''CD44-AS1''
 +
|[[CD44-AS1]]
 +
|RP1-68D18.4
 +
|CD44 antisense RNA 1
 +
|B cell lymphoma
 +
|-
 +
|''CEBPA-AS1''
 +
|[[CEBPA-AS1]]
 +
|N/A
 +
|CEBPA antisense RNA 1 (head to head)
 +
|Gastric cancer
 +
|-
 +
|''CERNA1''
 +
|[[CERNA1]]
 +
|LOC100129973
 +
|competing endogenous lncRNA 1 for miR-4707-5p and miR-4767
 +
|cardiovascular disease
 +
|-
 +
|''CERNA2''
 +
|[[CERNA2]]
 +
|HOST2
 +
|competing endogenous lncRNA 2 for microRNA let-7b
 +
|Ovarian cancer, Hepatocellular carcinoma
 +
|-
 +
|''CERNA3''
 +
|[[CERNA3]]
 +
|CTA
 +
|competing endogenous lncRNA 3 for miR-645
 +
|Osteosarcoma
 +
|-
 +
|''CFLAR-AS1''
 +
|[[CFLAR-AS1]]
 +
|ALS2CR10
 +
|CFLAR antisense RNA 1
 +
|hypertrophic scar
 +
|-
 +
|''CLMAT3''
 +
|[[CLMAT3]]
 +
|SPARC-AS1
 +
|colorectal liver metastasis associated transcript 3
 +
|colorectal cancer
 +
|-
 +
|''CSMD2-AS1''
 +
|[[CSMD2-AS1]]
 +
|ENST00000434181
 +
|CSMD2 antisense RNA 1
 +
|early-onset preeclampsia
 +
|-
 +
|''CYTOR''
 +
|[[CYTOR]]
 +
|C2orf59, NCRNA00152, LINC00152, MGC4677
 +
|cytoskeleton regulator RNA
 +
|Breast cancer, Gastric cancer
 +
|-
 +
|''CHMP1B-AS1''
 +
|[[CHMP1B-AS1]]
 +
|N/A
 +
|CHMP1B antisense RNA 1
 +
|_
 +
|-
 +
|''CLLU1''
 +
|[[CLLU1]]
 +
|N/A
 +
|chronic lymphocytic leukemia up-regulated 1
 +
|_
 
|}
 
|}

Latest revision as of 12:35, 29 June 2017

Jump to section in alphabetical order : A B C D E F G H I J K L M N O P R S T U V W X Y Z BACK

Name Transcript ID Alias Description Disease
C1QTNF9B-AS1 C1QTNF9B-AS1 PCOTH C1QTNF9B antisense RNA 1 prostate cancer
C21orf91-OT1 C21orf91-OT1 D21S2089E C21orf91 overlapping transcript 1 _
C5orf66-AS1 C5orf66-AS1 "CTC-276P9.1, Epist" C5orf66 antisense RNA 1 esophageal squamous cell carcinoma
C5orf66-AS2 C5orf66-AS2 N/A C5orf66 antisense RNA 2 _
C8orf34-AS1 C8orf34-AS1 N/A C8orf34 antisense RNA 1 _
CACNA1G-AS1 CACNA1G-AS1 N/A CACNA1G antisense RNA 1 keloid
CAHM ENST00000604200.1 LINC00468 colon adenocarcinoma hypermethylated (non-protein coding) colorectal neoplasia.
CAPN10-AS1 CAPN10-AS1 locus959 CAPN10 antisense RNA 1 (head to head) _
CAR Intergenic 10 NONHSAT016928,lnc-FANK1-3:1 "Intergenic10, CR611911, AK055628" Chromatin Associated RNA 10 _
CARD8-AS1 CARD8-AS1 LOC100505812 CARD8 antisense RNA 1 _
CARMN CARMN CARMEN cardiac mesoderm enhancer-associated non-coding RNA _
CASC11 CASC11 "TCONSN/A00014535, LINC00990, CARLo-7" cancer susceptibility candidate 11 (non-protein coding) colorectal cancer
CASC15 CASC15 N/A cancer susceptibility candidate 15 (non-protein coding) metastatic melanoma
CASC19 CASC19 CARLo-6 cancer susceptibility candidate 19 (non-protein coding) prostate cancer
CASC2 CASC2 N/A cancer susceptibility candidate 2 (non-protein coding) colorectal cancer
CASC21 CASC21 CARLo-2 cancer susceptibility candidate 21 (non-protein coding) _
CASC22 CASC22 "TCONSN/A00024290, LincRNA-ENST00000515084" cancer susceptibility candidate 22 (non-protein coding) breast cancer
CASC8 CASC8 "LINC00860,CARLo-1" cancer susceptibility candidate 8 (non-protein coding) Colorectal Cancer,Lung Cancer
CASC9 CASC9 "LINC00981, ESCCAL-1" cancer susceptibility candidate 9 (non-protein coding) predicted esophageal squamous cell carcinoma
CBR3-AS1 CBR3-AS1 PlncRNA-1 CBR3 antisense RNA 1 esophageal squamous carcinoma cell
CCAT1 NONHSAT129017 "CARLo-5, onco-lncRNA-40" colon cancer associated transcript 1 (non-protein coding) colorectal cance